Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith clippings of the Newspaper publication for Notice of the 41st AGM of the Company.

LAJENBURKT Jenburkt Pharmaceuticals Limited UNICORN, 14th Floor, Dattaji Salvi Marg, Off Veera Desai Road, Andheri West, Mumbai 400 053. Phone: 022-67 603 603 Ref, No. JPL/C$/23335/2026 Date : 04" August, 2026. BSE Ltd., P. J. Towers, Dalal Street, Mumbai - 400 001. Script Code : 524731 Reg. Regulation 47 and 30 read with Schedule UI Part A (Para A) of the Securities and Exchange Board of India isting Obligations and Disclosure Requirements Regulations, 2015. Sub.: Newspaper publication in pursuance of Rule 20(4) of the Companies (Management and Administration) Rules, 2014, in connection with the 41% Annual General Meeting of the Company. Dear Sir, With reference to our letter no. JPL/CS/2333/2026 dated 03™ August, 2026, addressed to the exchange, kindly note that the Company has completed dispatch of Annual Report 2025-26, inter-alia, containing notice convening 41“ Annual General Meeting of the Company, to all its members, on 03" August, 2026, by electronic mode in accordance to Rule 20(4) of the Companies (Management and Administration) Rules, 2014 and the Ministry of Corporate Affairs’s General Circulars No. 03/2025 dated 22™ September, 2025 and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. In terms of the captioned regulations, kindly find enclosed copies of the newspaper advertisement released by the Company, as required under the captioned Rule, as appeared in two Newspapers dated 04" August, 2026 viz.: (1) The Free Press Journal, Mumbai (English) and (2) Navshakti, Mumbai (Marathi). The above advertisement is also uploaded on the website of the Company, viz. www.jenburkt.com You are requested to take on record the same and acknowledge receipt. Thanking you, Yours faithfully, r Jenburkt Pharmace u ti cals Limited, DRM AS i ame ky fe y &: Science,hai johwatepaoba4l Hope hai toh Health hai 48} Health hai toh Happiness hai 3% ag Email: info@jenburkt.com www.jenburkt.com CIN No. L24230MH1985PLC036541 a 1 oO | THE FREE PRESS.JOURNAL | Mumbai, Tuesday, August 4, 2026 wwwifreepressjournalin JENB URKT Delivering Excellence in Life Sciences Jenburkt Pharmaceuticals Limited CIN: L24230MH1985PLC036541 Registered Office: UNICORN, 14th Floor, Dattaji Salvi Marg, Off Veera Desai Road, Andheri (West), Mumbai-400 053 022 - 67603603 4 Website: www.jenburkt.com @) E-mail: investor@jenburkt.com NOTICE TO MEMBERS NOTICE is hereby given that the 41° (Forty First) Annual General Meeting(“AGM") of Jenburkt Pharmaceuticals Limited (“the Company’) is scheduled on Friday, 04" September, 2026 at 3:30 p.m. IST by means of Video Conferencing ("VC") / Other Audio Visual Means (‘OAVM") to transact the business, as set out in the Notice of the AGM, in compliance with the applicable provisions of the Companies Act, 2013 (‘the Act’), read with rules made thereunder and the General Circular no. No 03/2025 dated 22nd September, 2025 (in continuation with the earlier Circulars in this regard) ("MCA Circulars") issued by the Ministry of Corporate Affairs ("MCA") and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI-LODR’) as amended. The Notice of the AGM along with the Annual Report for the Financial Year 2025-26 has been sent through electronic mode on 03rd August, 2026 to Members whose email addresses are registered with the Company, the Registrar to an Issue & Share Transfer Agent (RTA) or the Depository Participant(s) (DPs). The notice of the 41° AGM, inter alia, containing procedure and manner of remote e-voting, joining and voting at the AGM along with the Annual Report for the financial year 2025-26 are available on the Company's website at www.jenburkt.com and also on the websites of the Stock Exchanges i.e. BSE Limited at www.bseindia.com and displayed at https:/www.evoting.nsdl.com. In compliance with Section 108 of the Act read with Rule 20 of the Companies (Management and Administration) Rules, 2014 as amended, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements Regulations), 2015 (SEBI-LODR) and the MCAcirculars, members will be provided with the facility to cast their votes on all businesses set forth in the Notice of the AGM using electronic voting systemi.e. via remote e-voting, provided by National Securities Depository Limited. ("NSDL"), during time and dates as mentioned below: Commencement of remote e-voting : Tuesday, 01" September, 2026 at 9:00 a.m. IST End of remote e-voting : Thursday, 03" September, 2026 at 5:00 p.m. IST The remote e-Voting module shall be disabled by NSDL for voting thereafter. During this period, Members/beneficial owners holding shares either in physical form or in electronic form as on Friday, 28" August, 2026 (‘Cut-Off date’) only shall be entitled to cast their vote by remote e-Voting. Once the vote on a resolution is cast by the Member, the Member shall not be allowed to change it subsequently. Members attending at the AGM, who have not already cast their vote by remote e-Voting, are eligible to exercise their right to vote through e-Voting during the 41° AGM and 15 minutes after the Conclusion of the AGM. The voting rights of the Members shall be in proportion to the paid-up value of their shares in the equity capital of the Company as on the cut-off date being 28" August, 2026. The Members who have cast their vote by remote e-voting priotro the AGM may also attend the AGM through VC / OAVM but shall not be entitled to cast their vote again. The members attending the AGM through VC/OAVM shall be counted for the purpose of reckoning the quorum under section 103 of the Companies Act, 2013. As per Regulation 36(1)(b) of the SEBI -LODR, the letter mentioning web-link including the exact path, where complete details of the Annual Reportare available, is being sent to those member(s) who have not registered their email address(es) either with the Company or RTAof the Company or DPs. Any person holding shares in physical form and non-individual Members, who acquires shares and becomes member of the Company after the notice is sent through e-mail and holding shares as of the cut-offdatei.e. 28" August, 2026, or those who have not registered their email address with the company, may obtain the login ID and password by sending a request at evoting@nsdl.com or Company/RTA, to opt to vote through remote e-voting before or during the AGM. Members are requested to update/register their PAN, contact details, bank account details, specimen signature and nomination details with their Depository Participant (DP), if shares are held in dematerialised form. Physical Members shall update these details by submitting duly filled and signed Forms |SR-1 and ISR-2 to the Company/RTA. The said form can be downloaded from the Company's or RTA's website. Members can also submit their service requests online at the Company's RTA portal ‘iConnect’, which can be accessed at https:/ficonnect.bigshareonline.com/Account/Lagin. In case of any queries or grievances related to login id or remote e-voting facility, Members may refer the Frequently Asked Questions (FAQs) for Members and e-voting user manual for Members available at the download section of www.evoting.nsdl.com or can contact Ms. Veena Suvarna — Assistant Vice President- NSDL, email : evoting@nsdl.com, Tel.: 022 4886 7000, address: National Securities Depository Limited, 301, 3° Floor, Naman Chambers, G Block, Plot No-C-32, Bandra Kurla Complex, Bandra East, Mumbai- 400051. Members are requested to carefully read all the notes set out in the notice of the AGM and in particular instruction for joining the AGM and manner of casting vote through remote e-voting or e- voting at the AGM. By order of the Board, For Jenburkt Pharmaceuticals Limited, Sd/- Place : Mumbai Ashish R. Shah Date : 03" August, 2026 Sr, Vice President and Company Secretary This Notice is also available at Investor Section of the Company's website www.jenburkt.com and Corporate [Showing first 8,000 characters — download PDF for full document]